FDA has granted accelerated approval for Vonjo (pacritinib) capsules to treat adults who have a rare form of a bone marrow disorder known as intermediate or high-risk primary or secondary myelofibrosis...
Agreement gives groundbreaking human platelet company access to crucial technologies as it advances its program to manufacture human platelets at scale.